treating her2-positive solid tumors with tac t-cell therapy
Published 1 year ago • 136 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:13
tactic-2: tac01-her2, a tac t-cell therapy, in her2 tumors
-
1:58
tac t-cell development in solid tumors
-
1:39
anti-her2 autologous tac t cells in relapsed or refractory solid tumors
-
1:53
the application of car t-cell therapy for solid tumors
-
2:50
car-t cells versus spear t-cells to treat solid tumors
-
2:36
current challenges in targeting solid tumors with car t-cells
-
1:49
anti-her2 car macrophages for solid tumors
-
0:56
elucidating novel targets in solid tumors for car t-cell therapy
-
1:00
barriers to using car t-cells in solid tumors and strategies to overcome them
-
3:29
autologous macrophages with an anti-her2 car in her2 overexpressing solid tumors
-
4:37
armoring anti-her2 car-t cells with ccr8 and a dnr to enable efficacy in solid tumor models
-
1:28
challenges associated with car-t cells in solid tumors
-
4:05
enhancing car-t cell efficacy in solid tumors
-
0:53
expert addresses role of car t-cell therapy in solid tumors
-
7:16
her2-targeted car t-cell therapy safe, with promising antitumor activity in patients with advanc...
-
1:39
car-t therapy for lung cancer
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
59:27
updates in car t cell therapies
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer